Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
Sam Altman, already having a bad start to his week as a Chinese chatbot has put into doubt the lead of U.S. AI startups, is ...
Elon Musk asked a judge to block OpenAI's attempt to transition from nonprofit to for-profit. It's not the first time he's ...
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
OpenAI CEO Sam Altman is under fire for suggesting that artificial intelligence will upend societal norms after President ...
OpenAI has recently released its first AI agent, Operator. But how is it different from the ChatGPT platform? Let's find out.